Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17044627 | 0.84 | ALDH1A1 (0.31) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL17044576 | 0.83 | — | — | |
| SCHEMBL17044599 | 0.81 | — | — | |
| SCHEMBL17044591 | 0.81 | — | — | |
| SCHEMBL17044623 | 0.81 | — | — | |
| SCHEMBL11674210 | 0.78 | CYP2A6 (0.31) | ALDH1A1 | |
| SCHEMBL417802 | 0.77 | — | — | |
| SCHEMBL24252 | 0.77 | CYP2A6 (0.41) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL17044617 | 0.76 | — | — | |
| SCHEMBL17044604 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210069963-A1 | METHOD FOR MANUFACTURING A THREE-DIMENSIONAL OBJECT | SOLVAY SPECIALITY POLYMERS USA, LLC | 2021-03-11 | — | — | US | claimed |
| CN-111479874-A | Method for producing a three-dimensional object | 索尔维特殊聚合物美国有限责任公司 | 2020-07-31 | — | — | CN | claimed |
| US-9983441-B2 | Liquid crystal display device | MERCK PATENT GMBH (DE) | 2018-05-29 | — | — | US | claimed |
| US-7541071-B2 | Liquid-crystalline (METH) acrylate derivatives and composition containing them | CHISSO CORPORATION (JP) | 2009-06-02 | — | — | US | claimed |
| US-20060054859-A1 | Liquid-crystalline (METH) acrylate derivatives and composition containing them | JNC PETROCHEMICAL CORPORATION (JP) | 2006-03-16 | — | — | US | claimed |
| US-11795151-B2 | Benzotriazole compound | MIYOSHI OIL & FAT CO., LTD. (JP) | 2023-10-24 | — | — | US | disclosed |
| WO-2023162653-A1 | RESIST UNDERLAYER FILM FORMATION COMPOSITION | 日産化学株式会社 | 2023-08-31 | — | — | WO | disclosed |
| US-11654615-B2 | Method for manufacturing a three-dimensional object | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2023-05-23 | — | — | US | disclosed |
| CN-109963922-B | Aldehyde scavenger and method for removing aldehyde | 东曹株式会社 | 2022-09-23 | — | — | CN | disclosed |
| CN-113227214-A | Film-forming composition | 日产化学株式会社 | 2021-08-06 | — | — | CN | disclosed |
| US-20210069963-A1 | METHOD FOR MANUFACTURING A THREE-DIMENSIONAL OBJECT | SOLVAY SPECIALITY POLYMERS USA, LLC | 2021-03-11 | — | — | US | disclosed |
| US-20200325107-A1 | BENZOTRIAZOLE COMPOUND | MIYOSHI OIL & FAT CO., LTD. (JP) | 2020-10-15 | — | — | US | disclosed |
| EP-0786456-A2 | Addition compounds of triazolium- or tetrazolium-salts | BASF AKTIENGESELLSCHAFT (DE) | 1997-07-30 | — | — | EP | disclosed |
| EP-0772578-A1 | METHOD OF PRODUCING ACYLOINES | BAYER AG (DE) | 1997-05-14 | — | — | EP | disclosed |
| US-5585496-A | REACTING TRIAZOLIUM SALT WITH ALKANOLATE OR THIOLATE TO FORM ADDITION COMPOUND USED AS CATALYST FOR FORMALDEHYDE CONDENSATION | BASF AKTIENGESELLSCHAFT (DE) | 1996-12-17 | — | — | US | disclosed |
| US-5508422-A | USEFUL AS CATALYSTS IN FORMING CONDENSATION PRODUCTS OF FORMALDEHYDE | BASF AKTIENGESELLSCHAFT (DE) | 1996-04-16 | — | — | US | disclosed |
| WO-1996002484-A1 | METHOD OF PRODUCING ACYLOINES | BASF AKTIENGESELLSCHAFT (DE) | 1996-02-01 | — | — | WO | disclosed |
| US-5386062-A | Triazole or tetrazole compounds | BASF AKTIENGESELLSCHAFT (DE) | 1995-01-31 | — | — | US | disclosed |
| US-5298668-A | Forming glycolaldehyde, glyceraldehyde and C4 or C5 sugars by condensation in the presence of mesoionic catalyst | BASF AKTIENGESELLSCHAFT (DE) | 1994-03-29 | — | — | US | disclosed |
| EP-0587044-A2 | Method for the catalytic production of formaldehyde condensation products | BASF Aktiengesellschaft (DE) | 1994-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795151-B2 | Benzotriazole compound | PRXL2A, HAX1, XRN2 | ALDH1A1 2237/4885GLA 1759/4885MAPT 1459/4885 |
| US-20200325107-A1 | BENZOTRIAZOLE COMPOUND | PRXL2A, HAX1, XRN2 | ALDH1A1 2237/4885GLA 1759/4885MAPT 1459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.